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S poradic human infections with avian influenza A viruses, which usually occur after recent exposure to poultry, have caused a wide spectrum of illness, ranging from conjunctivitis and upper respiratory tract disease to pneumonia and multiorgan failure. Low pathogenic avian influenza A (H7N2, H7N3, H9N2, or H10N7) [1] [2] [3] [4] virus infections have caused lower respiratory tract illness that is mild (conjunctivitis or uncomplicated influenza-like illness) to moderate in severity. Most human infections with highly pathogenic avian influenza (HPAI) A (H7) viruses have resulted in conjunctivitis (H7N3) or uncomplicated influenza illness, but one case of fatal acute respiratory distress syndrome (ARDS) was reported in a patient with H7N7 virus infection during an outbreak in the Netherlands. 1, 5 In contrast, the cumulative case fatality rate since 2003 for reported cases of HPAI H5N1 virus infection is approximately 60%. [6] [7] [8] The transmission of H7 viruses to mammals has been reported only rarely 9 in Asia. Human infections with N9 subtype viruses had not been documented anywhere in the world. In February and March 2013, three patients were hospitalized with severe lower respiratory tract disease of unknown cause. We report the identification of a novel avian-origin reassortant influenza A (H7N9) virus associated with these infections.
Me thods

Surveillance, Reporting, and Data Collection
Throat-swab specimens obtained from three adult Chinese patients (two from Shanghai City and one from Anhui Province) who were hospitalized with severe bilateral pneumonia, leukopenia, and lymphocytopenia were sent to Shanghai Public Health Clinical Center, the Shanghai Centers for Disease Control and Prevention (CDC), and the Anhui CDC, respectively. After preliminary detection of respiratory pathogens, the samples were sent to the Chinese National Influenza Center (CNIC) on March 25, 2013 .
A standardized surveillance reporting form was used to collect epidemiologic and clinical data, including demographic characteristics; underlying medical conditions; history of seasonal influenza vaccination; recent exposures to swine, poultry, or other animals; recent visits to a live animal market; clinical signs and symptoms; chest radiographic findings; laboratory testing results, including diagnostic testing for influenza and other respiratory viruses; antiviral treatment; clinical complications; and outcomes. A confirmed case of human infection with avian-origin influenza A (H7N9) virus was defined as evidence of pneumonia with H7N9 viral RNA or isolation of H7N9 virus from respiratory specimens at the CNIC.
Isolation of the Virus
Throat-swab specimens obtained from all three patients were maintained in a viral-transport medium. The specimens were propagated in the allantoic sac and amniotic cavity of 9-to-11-day-old specific pathogen-free embryonated chicken eggs for 48 to 72 hours at 35°C.
RNA Extraction and Real-time RT-PCR
RNA was extracted from throat-swab samples with the use of the QIAamp Viral RNA Mini Kit (Qiagen), according to the manufacturer's instructions. Specific real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assays for seasonal influenza viruses (H1, H3, or B), H5N1, severe acute respiratory syndrome coronavirus (SARS-CoV), and novel coronavirus were used. Real-time RT-PCR assays with self-designed specific primer and probe sets for detecting H1 to H16 and N1 to N9 subtypes were then performed to verify the viral subtypes.
Genome Sequencing and Phylogenetic Analysis
A total of 198 primer sets were used to amplify the full genome for sequencing, with the use of Qiagen OneStep RT-PCR Kit. PCR products were purified from agarose gel with the use of the QIAquick Gel Extraction Kit (Qiagen). We performed the sequencing using an ABI 3730xl automatic DNA analyzer (Life Technologies) and the ABI BigDye Terminator v3.1 cycle sequencing kit (Life Technologies), according to the manufacturer's recommendations. Full genome sequences of the viruses from these patients were deposited in the Global Initiative on Sharing Avian Influenza Data (GISAID) database on March 29, 2013 (accession numbers are provided in Table  S1 in the Supplementary Appendix, available with the full text of this article at NEJM.org).
We performed multiple sequence alignments 3 with the ClustalW program using MEGA software, version 5.05. Phylogenetic trees were constructed by means of the neighbor-joining method with the use of MEGA software, version 5.05, to estimate the viral gene relationship with selected influenza A virus strains obtained from GenBank.
R e sult s
Patients
Patient 1 was an 87-year-old man with chronic obstructive pulmonary disease (COPD) and hypertension who reported a cough and sputum production at the onset of illness. High fever and dyspnea de- 4 veloped 1 week after the onset of illness. He had no known history of exposure to live birds during the 2 weeks before the onset of symptoms. Patient 2 was a 27-year-old man with a history of hepatitis B virus infection with positive hepatitis B surface antigen who presented to the hospital with high fever and cough. This patient was a butcher who worked at a market where there were transactions involving live birds. He sold pork but had not butchered bird meat before the onset of illness. Both Patient 1 and Patient 2 lived in Min-hang District, Shanghai, and were admitted to the Fifth People's Hospital.
Patient 3 was a 35-year-old woman who lived in Anhui Province. She had a history of depression, hepatitis B virus infection, and obesity. Patient 3 also had high fever and cough at the onset of the illness. She had visited a chicken market 1 week before the onset of symptoms. The demographic and epidemiologic characteristics of the three patients are summarized in Table 1 .
Determination of Causative Pathogens
We confirmed, by means of real-time RT-PCR, viral isolation, and full genome sequencing, that all three patients were infected with a novel avianorigin influenza A (H7N9) virus. Original clinical samples obtained from all three patients were confirmed, by means of real-time RT-PCR, to be positive for H7N9 and negative for seasonal influenza viruses (H1, H3 or B), H5N1, SARS-CoV, and HCoV-Erasmus Medical Center (EMC). Influenza viruses A/Shanghai/1/2013 (H7N9), A/ Shanghai/2/2013 (H7N9), and A/Anhui/1/2013 (H7N9) were isolated from Patients 1, 2, and 3, respectively. Complete sequences of the three H7N9 influenza viruses showed that they were 97.7 to 100% identical in all eight gene segments (see Table S1 in the Supplementary Appendix). Phylogenetic analysis of all genes of the isolates showed that each gene was of avian origin ( Fig. 1,  and Fig. S1 in the Supplementary Appendix). The gene encoding hemagglutinin (HA) shared the highest identity with A/duck/Zhejiang/12/2011 (H7N3, subtype ZJ12). The gene encoding neuraminidase (NA) protein was most closely related to A/wild bird/Korea/A14/2011 (H7N9, subtype KO14); however, the HA gene from the H7N9 viruses in our three patients was highly divergent from that in the KO14 virus. All six internal genes shared the highest similarity with A/brambling/ Beijing/16/2012-like viruses (H9N2) (Fig. 1) . Phylogenetic results indicated that it was a triple reassortant H7N9 virus (Fig. 2) .
In all three viruses, the HA cleavage site possesses only a single amino acid R (arginine), indicating low pathogenic effects in poultry. A T160A mutation was identified at the 150-loop (H3 numbering) in the HA gene of all three viruses. Substitution Q226L at the 210-loop in the HA gene was found in both the A/Anhui/1/2013 and A/Shanghai/2/2013 viruses but not in the A/ Shanghai/1/2013 virus ( Table 2) . Five amino acids were deleted in the stalk region of NA residue 69 to 73. The M2 protein contained the S31N substitution, indicating resistance to amantadine. Other mutations -89V and E627K in PB2 and 42S in NS1 -were also identified ( Table 2 ). The amino acids in A/Shanghai/1/2013, which differed from those in A/Anhui/1/2013 and A/Shanghai/2/2013, are shown in Table S2 in the Supplementary Appendix. To date, five additional H7N9 viruses have been isolated from five patients. Sequencing analysis indicates that all five viruses are highly similar to both A/ Shanghai/2/2013 and A/Anhui/1/2013. Some variability is observed, such as Q226L in HA and R292K in NA.
On the basis of these data, diagnostic tests for the novel reassortant H7N9 viruses have been developed. The specific sequences are available on the website of the World Health Organization (www.who.int/influenza/gisrs_ laboratory/a_h7n9/en/).
Clinical Features and Outcomes of the Patients
The clinical characteristics of the patients are shown in Table S3 in the Supplementary Appen- dix. Fever and cough were the most common symptoms. The white-cell count was normal or slightly decreased. Elevated levels of aspartate aminotransferase, creatine kinase, and lactate dehydrogenase were observed in all the patients. Bilateral ground-glass opacities and consolidation were detected on chest radiography (Fig. 3) . Several complications of the illness were ob- served. All the patients had ARDS. Patient 3 had septic shock and acute renal damage. Carbapenem-resistant Acinetobacter baumannii was cultured from lower respiratory tract specimens obtained from two of the patients after the initiation of mechanical ventilation. Combination antibiotic therapy, glucocorticoids, and intravenous immunoglobulin were administered in all three patients. Antiviral therapy was initiated 6 to 7 days after the onset of illness (Table 1) . Patient 1 declined admission to the intensive care unit (ICU) and intubation. He died from refractory hypoxemia 13 days after the onset of illness. Patient 2 was admitted to the ICU and intubated 48 hours after admission owing to progressive dyspnea. He died from refractory hypoxemia after 4 days in the ICU. ARDS and septic shock developed in Patient 3 on day 6 after the onset of illness. She was admitted to the ICU, and extracorporeal membrane oxygenation was initiated. She died on April 9.
Discussion
We have identified a novel reassortant influenza A (H7N9) virus that is associated with severe human infection. Currently, only 25 H7N9 viruses are available in GenBank. The H7N9 viruses we identified in the three patients were of avian origin, but only the NA gene was closely related to that from another H7N9 virus (KO14). The HA gene was similar to that of an H7N3 virus (ZJ12) from a nearby region (Zhejiang Province) in China. All the internal gene segments were closely related to those from avian H9N2 viruses, particularly a virus isolated from a brambling in Bei- jing (BJ16) (Fig. 1, and Fig. S1 in the Supplementary Appendix). Thus, the human H7N9 viruses are the product of reassortment of viruses that are of avian-origin only. In addition, the phylogenetic trees showed that A/Shanghai/1/2013 is phylogenetically distinct from A/Anhui/1/2013 and A/Shanghai/2/2013 across all gene segments, which suggests that there have been at least two introductions into humans (Fig. 1, and Fig. S1 in the Supplementary Appendix). Currently, there are no data to suggest that this reassortment occurred in a mammalian host, and the similarity of the human viruses to avian viruses may be stronger support for direct avian transmission of this virus. However, influenza surveillance of birds, swine, and humans is limited in China and nearby countries, making it difficult to resolve this question.
Although human infections with avian-origin H7 avian influenza viruses have been observed before, 1,2,5,10,11 infection of humans with an N9 subtype influenza virus has not been reported previously. Human H7 influenza infections are generally mild, causing conjunctivitis or modest respiratory symptoms, although a fatal case was reported before this H7N9 outbreak. 5 All three cases of H7N9 infection reported here were virulent, with the patients' conditions deteriorating rapidly with the development of severe pneumonia and ARDS, and ultimately resulted in death. All the patients had preexisting medical conditions, and two had a history of direct contact with poultry. Two patients presented with rhabdomyolysis, which has rarely been reported in patients infected with H1N1 or H5N1 12 influenza viruses. Encephalopathy, which is normally more common in pediatric patients with influenza, 13 was observed in two patients.
The affinity of the influenza virus to different sialyl-sugar structures is an important determinant of range and pathogenicity in the viral host. 14, 15 Human influenza viruses preferentially bind to α2,6 sialyl glycan, whereas most avian viruses bind to α2,3 sialyl glycan. 16, 17 Q226L in the HA protein, which was first reported in H7 field viruses, as well as H5 subtypes, was expected to bind strongly to α-2,6 human-like receptors. A laboratory-produced Q226L mutation at the 210-loop of HA has been shown to change the receptor binding of avian origin to a human- A chest radiograph (patient's heart is on the right side) of Patient 1 is shown in Panels A and B . Mild groundglass opacity was observed on day 6 (Panel A). Bilateral ground-glass opacity and consolidation were clearly seen on day 9 (Panel B). A computed tomographic scan of the chest of Patient 1, obtained on day 7 (the day of admission), is shown in Panels C and D. Substantial bilateral ground-glass opacity and consolidation can be seen. Chest radiographs of Patient 2, obtained on day 7 and day 13 after the onset of illness are shown in Panels E and F, respectively. Bilateral groundglass opacity and consolidation can be seen on day 7, and white lungs on day 13. Chest radiographs of Patient 3 on day 7 and day 13 after the onset of illness are shown in Panels G and H. Bilateral ground-glass opacity and consolidation can be seen on both day 7 and day 13. 
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type receptor binding and might increase the ability of the virus to be transmitted by air, as reported previously. 18, 19 Moreover, the lack of a glycosylation site on the 150-loop might decrease the affinity to α-2,3 avian-like receptors. The effects of these mutations require further study.
A deletion of five amino acids in the viral NA stalk has been observed in the novel reassortant H7N9 viruses. A similar deletion in the H5N1 avian virus has been shown to be responsible for the change in viral tropism to the respiratory tract 20 or to enhance viral replication, 21 and it has been suggested that this deletion may be associated with adaptation and transmission in domestic poultry. 22, 23 Since April 4, it has been reported that H7N9 viruses similar to those isolated from the three patients described here have been isolated from pigeons and chickens, indicating that the novel H7N9 viruses might currently be circulating in poultry. Moreover, the E627K substitution in the PB2 gene has been associated with increased virulence in mice and was reported to be associated with improved replication of avian influenza viruses in mammals. 24, 25 A combination of these substitutions may contribute to the human infection and severe disease. Other possible virulence molecular markers are shown in Table 2 . The potential virulence mutations are described on the basis of previous studies in animals, but the pathogenesis in humans remains unknown.
The difference between the two Shanghai viruses and the similarity between the Shanghai/2 and Anhui/1 viruses argue against human-tohuman transmission in these cases, and no close contacts of the patients have tested positive for these viruses. However, limited human-tohuman transmission was observed in the H7 outbreak in the Netherlands in 2003 10 ; therefore, the pandemic potential of these novel avian-origin viruses should not be underestimated.
Currently there is no vaccine available for these novel viruses, and it is not known whether the current candidate H7 vaccine viruses, of which three are North American viruses and the other three are avian viruses from 2000 in the Netherlands, may be effective. The influenza H7N9 A/Anhui/1/2013 strain has been proposed to be one of the candidate vaccine strains since it grows to a very high titer in eggs. Heightened protective measures should be taken when dealing with these viruses, and increased surveillance and analyses of these viruses are needed.
Severe avian influenza A (H7N9) infections, characterized by high fever and severe respiratory symptoms, may pose a serious human health risk. We are concerned by the sudden emergence of these infections and the potential threat to the human population. An understanding of the source and mode of transmission of these infections, further surveillance, and appropriate counter measures are urgently required.
